Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma

Journal of Investigative Dermatology

Volumn 117, Issue 6, 2001, Pages 1483-1489

  Demunter, Anouk ^a   Stas, Marguerite ^a   Degreef, Hugo ^b   De Wolf Peeters, Chris ^a   Van Den Oord, Joost J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinogenesis; DGGE; Melanoma; Microdissection; Ras

Indexed keywords

ARTICLE; CANCER GROWTH; CODON; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; EXON; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; NEVUS CELL; ONCOGENE K RAS; ONCOGENE N RAS; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKIN METASTASIS;

EID: 0035670803     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01601.x     Document Type: Article

References (37)

1. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression
2. Analysis of ras oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with differentiation phenotype
3. RAS mutations in human melanoma a marker of malignant progression
4. RAS genes
5. N-RAS mutations in T-cell acute lymphocytic leukemia: Analysis by direct sequencing detects a novel mutation
6. Identification of multiple mRNA and DNA sequences from small tissue samples isolated by laser-assisted microdissection
7. The ras gene family and human carcinogenesis
8. Amino-acid substitutions at codon 13 of the N-RAS oncogene in human acute myeloid leukemia
9. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
10. Point mutations in the N-ras oncogene in malignant melanoma and congential nevi
11. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
12. Model predicting survival in stage I melanoma based on tumor progression
13. A novel N-Ras mutation in malignant melanoma is associated with excellent prognosis
14. Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus
15. Tumor progression, early diagnosis and prognosis of melanoma
16. G proteins and dual control of adenylate cyclase
17. Lessons from tumor progression: The invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent
18. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin
19. Tumor progression in the human melanocytic system
20. Sunlight and cutaneous malignant melanoma: Evidence for and against causation
21. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization
22. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus
23. Human oncogenes
24. Molecular clonality of in-transit melanoma metastasis
25. Analysis of Ras oncogene mutations in human lymphoid malignancies
26. Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations
27. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
28. Sensitivity of melanoma cell lines to natural killer cells: A role for oncogene-modulated HLA class I expression?
29. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-β
30. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
31. Structure and activation of the human N-RAS gene
32. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer
33. Activation of N-ras induced by ultraviolet irradiation in vitro
34. Analysis of N-ras mutations in human cutaneous melanoma: Tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis
35. N-RAS mutations in human cutaneous melanoma from sun-exposed body sites
36. A dot-blot screening procedure for mutated RAS oncogenes using synthetic oligonucleotides
37. Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissection and comparative genomic hybridization